NCT06963827 · Interventional
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Kidney Disease
Study overall: Recruiting · source record updated 14 August 2026.
10 England locations · 10 explicitly recorded as recruiting.
RESEARCH IN ENGLAND
Explore clinical trials with England locations
Search 2,970 registered studies with identifiable England locations in our dated ClinicalTrials.gov snapshot. Explore the study and local recruitment details before contacting the research team.
27 matching studies · ordered by study identifier.
The area filter uses exact source postcodes. Locations without a matched postcode remain in the England-wide results.
NCT06973187 · Interventional
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
Study overall: Recruiting · source record updated 26 August 2026.
6 England locations · 6 explicitly recorded as recruiting.
NCT07044336 · Interventional
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Endometrial Cancer · Malignant Solid Tumour
Study overall: Recruiting · source record updated 29 July 2026.
9 England locations · 6 explicitly recorded as recruiting.
NCT07218809 · Interventional
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
Epithelial Ovarian Cancer
Study overall: Recruiting · source record updated 21 July 2026.
9 England locations · 5 explicitly recorded as recruiting.
NCT07228832 · Interventional
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Metastatic Colorectal Cancer (CRC)
Study overall: Recruiting · source record updated 8 September 2026.
4 England locations · 4 explicitly recorded as recruiting.
NCT07258511 · Interventional
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Study overall: Recruiting · source record updated 28 August 2026.
5 England locations · 5 explicitly recorded as recruiting.
NCT07767058 · Interventional
Mindfulness for Central Serous Chorioretinopathy
Central Serous Chorioretinopathy
Study overall: Not yet recruiting · source record updated 28 August 2026.
6 England locations · 0 explicitly recorded as recruiting.
More ways to explore research
This is a selected international registry feed, not every study taking place in England. NIHR also lists participation opportunities, including studies that may not appear in this selection.
Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).
Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.
How we selected and connected these records
Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.